"When you or a loved one has heart problems, you want cardiac experts with the skill, commitment, and compassion to give you the finest possible heart care. At AdventHealth Pepin Heart Institute, formerly Florida Hospital Pepin Heart Institute, that means more than treatment for your heart problem. We're at your side at every step from diagnosis to recovery and beyond — supporting your physical, emotional, and spiritual needs throughout your journey."

During the past decade, Florida Hospital Pepin Heart Institute conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 10 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 7 clinical trials were completed. i.e. 700% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Florida Hospital Pepin Heart Institute" #1 sponsor was "Juventas Therapeutics, Inc." with 2 trials, followed by "Abbott Medical Devices" with 1 trials sponsored, "Angel Medical Systems" with 1 trials sponsored, "Astellas Pharma Inc" with 1 trials sponsored and "AtriCure, Inc." with 1 trials sponsored. Other sponsors include 11 different institutions and companies that sponsored additional 21 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Florida Hospital Pepin Heart Institute" #1 collaborator was "Abbott" with 1 trials as a collaborator, "BTG International Inc." with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator and "Cordis Corporation" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Florida Hospital Pepin Heart Institute" are "Coronary Artery Disease" (4 trials), "Ischemic Heart Failure" (2 trials), "Myocardial Ischemia" (2 trials), "Acute Coronary Syndrome" (1 trials) and "Acute Kidney Injury (AKI)" (1 trials). Many other conditions were trialed in "Florida Hospital Pepin Heart Institute" in a lesser frequency.

Most popular intervention types in "Florida Hospital Pepin Heart Institute" are "Device" (13 trials), "Drug" (4 trials), "Biological" (2 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "(BMS/DES)" (1 trials), "ACE-I (lisinopril) or ARB (losartan)" (1 trials), "ADRCs processed by the Celution System" (1 trials) and "ASP1128" (1 trials). Other intervention names were less common.

The vast majority of trials in "Florida Hospital Pepin Heart Institute" are 21 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Florida Hospital Pepin Heart Institute". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Florida Hospital Pepin Heart Institute, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Florida Hospital Pepin Heart Institute, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 7 trials that are defined as “Not Applicable".